CD36 and metabolic dysfunction-associated steatotic liver disease: Other studies using animal models of NAFLD suggested a causal role of CD36 in hepatic lipid accumulation, which were supported by a positive correlation between the expression level of CD36 and the extent of hepatic lipid accumulation [44,45].